Wednesday, June 15, 2016
Potassium Chloride Powder Products
David A. Hickerson
Foley & Lardner LLP
Lehigh Valley Technologies, Inc., Endo Global Ventures, Endo Ventures Limited and Generics Bidco I, LLC (d/b/a Qualitest Pharmaceuticals and Par Pharmaceutical)
Letter to Lisa R. Barton, Secretary, USITC; requesting that the Commission conduct an investigation under section 337 of the Tariff Act of 1930, as amended, regarding Certain Potassium Chloride Powder Products. The proposed respondents are: Viva Pharmaceutical Inc., Canada; Virtus Pharmaceuticals, LLC, Tampa, Florida; and Virtus Pharmaceuticals OPCO II, LLC, Nashville, Tennessee.